Table 1 Characteristics of ITT clinical trial population
Variable | Chloroquine-azithromycin CQ/AZ (N = 15) | Chloroquine (CQ) (N = 8) | All subjects (N = 23) |
|---|---|---|---|
Age (years) | |||
 n | 15 | 8 | 23 |
 Mean (SD) | 30.6 (6.38) | 33.5 (6.78) | 31.6 (6.52) |
 Median | 31.0 | 35.0 | 32.0 |
 Min, max | 21, 43 | 23, 41 | 21, 43 |
 Two sample t-test p-value | 0.3209 |  |  |
Gender: n (%) | |||
 Male | 8 (53.3%) | 3 (37.5%) | 11 (47.8%) |
 Female | 7 (46.7%) | 5 (62.5%) | 12 (52.2%) |
 Undifferentiated | 0 | 0 | 0 |
 Fisher’s exact test p-value | 0.6668 |  |  |
Ethnicity: n(%) | |||
 Hispanic or Latino | 1 (6.7%) | 1 (12.5%) | (8.7%) |
 Not hispanic or latino | 14 (93.3%) | 7 (87.5%) | (91.3%) |
 Fisher’s exact test p-value | > 0.9999 |  |  |
Race: n (%) | |||
 American Indian or Alaska | 0 | 0 | 0 |
 Asian | 2 (13.3%) | 0 | 2 (8.7%) |
 Black or African American | 3 (20.0%) | 1 (12.5%) | 4 (17.4%) |
 Native Hawaiian or Other Islander | 0 | 0 | 0 |
 White | 9 (60.0%) | 5 (62.5%) | (4 60.9%) |
 Other | 0 | 0 | 0 |
Multi-racial | 1 (6.7%) | 2 (25.0%) | 3 (13.0%) |
 Fisher’s exact test | 0.6815 |  |  |